DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Corey GR, Kollef MH, Shorr AF. et al.
Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival.
Antimicrob Agents Chemother 2014;
58: 2030-2037
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.